Safinamide Mesylate
Home / API - Under Development / Safinamide Mesylate
Therapeutic Category
- Anti-Parkinson
Innovator Brand
Xadago; Equfina;Onstryv
GMP
Not Available
DMF
Not Available
Filed
-
Under Filing
-
Sample
Available
Indication
Safinamide Mesylate, a mesylate salt form of Safinamide.It is used to treat idiopathic Parkinson’s disease as add-on for people in combination with other Parkinson drugs, to help with “off” episodes when other drugs stops working.
Disclaimer: CTX Lifesciences respects patent laws and conventions of pharmaceuticals as applicable in different countries.
API/Substances covered by patent are not offered to the countries where the patent law is in force. However, the final responsibility lies with the customer.